ReNeu: A pivotal phase 2b trial of mirdametinib in children and adults with neurofibromatosis type 1 (NF1)-associated symptomatic inoperable plexiform neurofibroma (PN). Meeting Abstract

cited authors

  • Moertel, Christopher L.; Hirbe, Angela C.; Shuhaiber, Hans H.; Viskochil, David; Sidhu, Alpa; Bielamowicz, Kevin J.; Weber, Michael; Li, Jack; Smith, L. Mary; Weintraub, Lauren; McNall-Knapp, Rene Y.; Hajjar, Fouad M.; Foreman, Nicholas K.; Gershon, Timothy R.; Babovic-Vuksanovic, Dusica; ReNeu Study Grp

Publication Date

  • June 1, 2024

webpage

published in

category

volume

  • 42

issue

  • 16